Literature DB >> 27699527

Epidemiology of HPV-Positive Tumors in Europe and in the World.

Xavier Castellsagué1, Marisa Mena2, Laia Alemany2.   

Abstract

Strong evidence has accumulated in the last 15 years showing that infection by certain human papillomaviruses (HPVs) is etiologically involved in a subset of head and neck cancers (HNCs). In this chapter, epidemiologic-related topics on HNCs are reviewed: (i) HPV-attributable fractions and HPV-type distributions by different anatomical HNC sites, using not only HPV DNA but other more specific markers of causality; (ii) an update of the HPV-related HNCs burden worldwide and by regions; and finally, (iii) the determinants for HPV positivity in HNCs, focussing on gender, age, smoking habits, sexual behavior, and other related factors such as tonsillectomy performance. This information is essential in order to understand the burden of the disease and its dynamics and changing patterns, as well as for planning and assessment of the potential impact of HPV-based preventive strategies for HNCs.

Entities:  

Keywords:  Burden of disease; Epidemiology; HPV; Head and neck cancer

Mesh:

Substances:

Year:  2017        PMID: 27699527     DOI: 10.1007/978-3-319-43580-0_2

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  11 in total

1.  Oral gargle-tumor biopsy human papillomavirus (HPV) agreement and associated factors among oropharyngeal squamous cell carcinoma (OPSCC) cases.

Authors:  Laura Martin-Gomez; William J Fulp; Michael J Schell; Bradley Sirak; Martha Abrahamsen; Kimberly A Isaacs-Soriano; Attila Lorincz; Bruce Wenig; Christine H Chung; Jimmy J Caudell; Anna R Giuliano
Journal:  Oral Oncol       Date:  2019-04-03       Impact factor: 5.337

2.  Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16.

Authors:  Beata Biesaga; Anna Mucha-Małecka; Anna Janecka-Widła; Marta Kołodziej-Rzepa; Sława Szostek; Dorota Słonina; Aleksandra Kowalczyk; Krzysztof Halaszka; Marcin Przewoźnik
Journal:  J Cancer Res Clin Oncol       Date:  2017-10-17       Impact factor: 4.553

3.  A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice.

Authors:  Farhad Motavalli Khiavi; Arash Arashkia; Majid Golkar; Maryam Nasimi; Farzin Roohvand; Kayhan Azadmanesh
Journal:  J Immunol Res       Date:  2018-05-03       Impact factor: 4.818

4.  Might Oral Human Papillomavirus (HPV) Infection in Healthy Individuals Explain Differences in HPV-Attributable Fractions in Oropharyngeal Cancer? A Systematic Review and Meta-analysis.

Authors:  Marisa Mena; Miren Taberna; Laura Monfil; Marc Arbyn; Silvia de Sanjosé; Francesc Xavier Bosch; Laia Alemany; Laia Bruni
Journal:  J Infect Dis       Date:  2019-04-19       Impact factor: 5.226

Review 5.  Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck.

Authors:  Karla Santos-de-Frutos; Carmen Segrelles; Corina Lorz
Journal:  J Clin Med       Date:  2019-12-03       Impact factor: 4.241

Review 6.  Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting.

Authors:  Sreedhar Amere Subbarao
Journal:  Inflammopharmacology       Date:  2021-03-15       Impact factor: 5.093

7.  Role of P16 Expression in the Prognosis of Patients With Laryngeal Cancer: A Single Retrospective Analysis.

Authors:  Eugenia Allegra; Maria Rita Bianco; Chiara Mignogna; Rosario Caltabiano; Maria Grasso; Lidia Puzzo
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

8.  The evolution of the epidemiological landscape of head and neck cancer in Italy: Is there evidence for an increase in the incidence of potentially HPV-related carcinomas?

Authors:  Paolo Boscolo-Rizzo; Manuel Zorzi; Annarosa Del Mistro; Maria Cristina Da Mosto; Giancarlo Tirelli; Carlotta Buzzoni; Massimo Rugge; Jerry Polesel; Stefano Guzzinati
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

9.  mRNA and miRNA Profiles of Exosomes from Cultured Tumor Cells Reveal Biomarkers Specific for HPV16-Positive and HPV16-Negative Head and Neck Cancer.

Authors:  Sonja Ludwig; Priyanka Sharma; Petra Wise; Richard Sposto; Deborah Hollingshead; Janette Lamb; Stephan Lang; Muller Fabbri; Theresa L Whiteside
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

10.  Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank.

Authors:  Nicole Brenner; Alexander J Mentzer; Michael Hill; Rachael Almond; Naomi Allen; Michael Pawlita; Tim Waterboer
Journal:  EBioMedicine       Date:  2020-11-25       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.